Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors

NCT07586813 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Persistent Isolated Chemotherapy-Induced Thrombocytopenia
Chemotherapy-Induced Thrombocytopenia
Gastrointestinal Neoplasms
Pancreatic Cancer
Colorectal Cancer

Interventions

DRUG: Romiplostim N01
DRUG: All-trans retinoic acid

Sponsor

Peking University People's Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]